Capitol Health Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Capitol HealthDie Gewinne des Unternehmens sind mit einer durchschnittlichen jährlichen Rate von -52.1% zurückgegangen, während in der Branche Healthcare die Gewinne mit einer durchschnittlichen jährlichen Rate von 3.3% zurückgehen. Die Umsätze sind gewachsen mit einer durchschnittlichen Rate von 9.4% pro Jahr.

Wichtige Informationen

-52.1%

Wachstumsrate der Gewinne

-56.2%

EPS-Wachstumsrate

Healthcare Wachstum der Industrie	2.4%
Wachstumsrate der Einnahmen	9.4%
Eigenkapitalrendite	-13.3%
Netto-Marge	-6.3%
Letzte Ertragsaktualisierung	30 Jun 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 05

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Feb 14

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Jan 19

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Dec 22

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Dec 01

Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Aug 17

Is Now An Opportune Moment To Examine Capitol Health Limited (ASX:CAJ)?

Jul 25

Is Capitol Health Limited's (ASX:CAJ) Latest Stock Performance A Reflection Of Its Financial Health?

Jul 04

Aufschlüsselung der Einnahmen und Ausgaben

Wie Capitol Health Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

ASX:CAJ Einnahmen, Ausgaben und Erträge (AUD Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten
30 Jun 24	235	-15	7
31 Mar 24	232	-5	7
31 Dec 23	229	6	7
30 Sep 23	219	-3	7
30 Jun 23	210	-12	7
31 Mar 23	198	-12	6
31 Dec 22	187	-12	5
30 Sep 22	186	-1	5
30 Jun 22	184	11	5
31 Mar 22	186	12	5
31 Dec 21	188	14	5
30 Sep 21	183	13	5
30 Jun 21	178	12	5
31 Mar 21	168	8	5
31 Dec 20	159	4	4
30 Sep 20	156	3	4
30 Jun 20	154	1	4
31 Mar 20	156	8	6
31 Dec 19	157	15	8
30 Sep 19	153	20	9
30 Jun 19	149	24	11
31 Dec 18	137	-2	8
30 Sep 18	128	-6	8
30 Jun 18	119	-11	8
31 Dec 17	110	2	12
30 Sep 17	108	2	12
30 Jun 17	107	2	12
31 Dec 16	80	1	9
30 Sep 16	92	2	10
30 Jun 16	104	2	11
31 Mar 16	148	-2	17
31 Dec 15	139	1	16
30 Sep 15	125	3	14
30 Jun 15	110	4	13
31 Mar 15	103	6	12
31 Dec 14	95	9	12
30 Sep 14	92	8	11
30 Jun 14	90	7	11
31 Mar 14	83	6	10
31 Dec 13	77	5	9

Qualität der Erträge: CAJ ist derzeit unrentabel.

Wachsende Gewinnspanne: CAJ ist derzeit unrentabel.

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: CAJ ist unrentabel, und die Verluste haben in den letzten 5 Jahren mit einer Rate von 52.1% pro Jahr zugenommen.

Beschleunigtes Wachstum: Das Gewinnwachstum des letzten Jahres kann nicht mit dem 5-Jahres-Durchschnitt von CAJ verglichen werden, da das Unternehmen derzeit nicht profitabel ist.

Erträge im Vergleich zur Industrie: CAJ ist unrentabel, was einen Vergleich des Gewinnwachstums des letzten Jahres mit der Branche Healthcare (-25.4%) erschwert.

Eigenkapitalrendite

Hohe Eigenkapitalrendite: CAJ hat eine negative Eigenkapitalrendite (-13.34%), da es derzeit unrentabel ist.

Capitol Health Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

Full year 2024 earnings released: AU$0.014 loss per share (vs AU$0.011 loss in FY 2023)

Capitol Health Limited to Report Fiscal Year 2024 Results on Aug 22, 2024

First half 2024 earnings released: EPS: AU$0.002 (vs AU$0.015 loss in 1H 2023)

Capitol Health Limited to Report First Half, 2024 Results on Feb 29, 2024

Full year 2023 earnings: EPS misses analyst expectations

Capitol Health Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Recent updates

Insufficient new directors

Capitol Health Limited, Annual General Meeting, Feb 28, 2025

Final dividend of AU$0.004 announced

Price target increased by 7.1% to AU$0.31

Full year 2024 earnings released: AU$0.014 loss per share (vs AU$0.011 loss in FY 2023)

Capitol Health Limited Provides Earnings Guidance for the Year 2025

Capitol Health Limited to Report Fiscal Year 2024 Results on Aug 22, 2024

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Calculating The Fair Value Of Capitol Health Limited (ASX:CAJ)

Now 21% undervalued after recent price drop

Now 21% undervalued

First half dividend of AU$0.005 announced

First half 2024 earnings released: EPS: AU$0.002 (vs AU$0.015 loss in 1H 2023)

New major risk - Financial position

Now 20% undervalued

Capitol Health Limited to Report First Half, 2024 Results on Feb 29, 2024

Capitol Health Limited Appoints Brendon Pentland as the Chief Financial Officer, Effective 1 April 2024

Capitol Health Limited's (ASX:CAJ) Popularity With Investors Is Clear

Capitol Health (ASX:CAJ) Takes On Some Risk With Its Use Of Debt

Now 21% undervalued

Now 21% undervalued after recent price drop

Capitol Health Limited Announces the Resignation of Craig Bremner as Chief Financial Officer

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Price target decreased by 9.8% to AU$0.28

Capitol Health Limited, Annual General Meeting, Nov 15, 2023

Full year 2023 earnings: EPS misses analyst expectations

Capitol Health Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Price target decreased by 9.6% to AU$0.33

Capitol Health Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 21% undervalued

Now 21% undervalued

Capitol Health Limited (ASX:CAJ) completed the acquisition of Future Medical Imaging Group Pty Ltd.

Is Capitol Health Limited (ASX:CAJ) Worth AU$0.3 Based On Its Intrinsic Value?

Capitol Health Limited Declares Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Price target increased to AU$0.43

Capitol Health Limited, Annual General Meeting, Nov 15, 2022

Full year 2022 earnings: EPS misses analyst expectations

Capitol Health Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 October, 2022

Consensus EPS estimates fall by 12%

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Capitol Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on April 1, 2022

Capitol Health Limited to Report First Half, 2022 Results on Feb 24, 2022

Full year 2021 earnings released: EPS AU$0.012 (vs AU$0.001 in FY 2020)

Capitol Health (ASX:CAJ) Seems To Use Debt Rather Sparingly

Should You Investigate Capitol Health Limited (ASX:CAJ) At AU$0.37?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Analysts increase EPS estimates to AU$0.012

First half 2021 earnings released: EPS AU$0.006 (vs AU$0.004 in 1H 2020)

Price target raised to AU$0.36

New 90-day high: AU$0.34

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Capitol Health Limited (ASX:CAJ) acquired Direct Radiology.

Capitol Health Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$0.28

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Price target raised to AU$0.31

Capitol Health Limited (ASX:CAJ) entered into a binding agreement to acquire Direct Radiology for AUD 12 million.

Capitol Health Limited (ASX:CAJ) entered into a binding agreement to acquire Direct Radiology for AUD 12 million.

New 90-day high: AU$0.27

Capitol Health Limited Appoints Craig Bremner as Chief Financial Officer, November 9, 2020

Capitol Health Limited Announces Resignation of Marcell Judkins as Chief Financial Officer

Price target raised to AU$0.27

Capitol Health Limited (ASX:CAJ) completed the acquisition of 90% stake in Fowler Simmons Radiology.

Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Capitol Health Limited to Report Fiscal Year 2020 Results on Aug 26, 2020